Annual ROE
-20.82%
+41.62%+66.66%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual return on equity is -20.82%, with the most recent change of +41.62% (+66.66%) on March 1, 2024.
- During the last 3 years, GRCE annual ROE has risen by +36.51% (+63.68%).
- GRCE annual ROE is now -343.92% below its all-time high of -4.69%, reached on February 1, 2015.
Performance
GRCE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-19.19%
-1.06%-5.85%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly return on equity is -19.19%, with the most recent change of -1.06% (-5.85%) on September 1, 2024.
- Over the past year, GRCE quarterly ROE has increased by +39.69% (+67.41%).
- GRCE quarterly ROE is now -105.39% below its all-time high of 356.13%, reached on February 1, 2011.
Performance
GRCE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GRCE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.7% | +67.4% |
| 3 y3 years | +63.7% | -18.7% |
| 5 y5 years | +95.4% | +98.1% |
GRCE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -129.6% | +66.7% | -89.1% | +67.4% |
| 5 y | 5-year | -129.6% | +95.4% | -180.1% | +97.9% |
| alltime | all time | -343.9% | +95.4% | -105.4% | +98.1% |
Grace Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -19.19%(+5.8%) |
| Jun 2024 | - | -18.13%(-9.3%) |
| Mar 2024 | -20.82%(-66.7%) | -19.99%(-66.0%) |
| Dec 2023 | - | -58.88%(+8.0%) |
| Sep 2023 | - | -54.53%(+6.9%) |
| Jun 2023 | - | -51.00%(+11.0%) |
| Mar 2023 | -62.44%(+588.4%) | -45.96%(+172.9%) |
| Dec 2022 | - | -16.84%(+4.1%) |
| Sep 2022 | - | -16.17%(+57.8%) |
| Jun 2022 | - | -10.25%(+1.0%) |
| Mar 2022 | -9.07%(-84.2%) | -10.15%(-26.6%) |
| Dec 2021 | - | -13.83%(-21.7%) |
| Sep 2021 | - | -17.67%(-65.0%) |
| Jun 2021 | - | -50.46%(-41.4%) |
| Mar 2021 | -57.33%(-73.0%) | -86.10%(-459.2%) |
| Dec 2020 | - | 23.97%(-120.4%) |
| Sep 2020 | - | -117.43%(-77.1%) |
| Jun 2020 | - | -513.91%(-16.3%) |
| Mar 2020 | -212.26%(-53.1%) | -614.35%(-33.6%) |
| Dec 2019 | - | -925.05%(-7.9%) |
| Sep 2019 | - | -1004.50%(+40.3%) |
| Jun 2019 | - | -715.75%(+20.8%) |
| Mar 2019 | -452.14%(+207.4%) | -592.35%(+27.8%) |
| Dec 2018 | - | -463.36%(-32.9%) |
| Sep 2018 | - | -690.81%(+248.2%) |
| Jun 2018 | - | -198.40%(+42.5%) |
| Mar 2018 | -147.08%(+217.1%) | -139.20%(+57.7%) |
| Dec 2017 | - | -88.27%(+44.8%) |
| Sep 2017 | - | -60.95%(+27.2%) |
| Jun 2017 | - | -47.91% |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | -46.39%(+132.1%) | - |
| Nov 2016 | - | -40.04%(+11.8%) |
| Aug 2016 | - | -35.81%(+23.6%) |
| May 2016 | - | -28.97%(+44.6%) |
| Feb 2016 | -19.99%(+326.2%) | -20.04%(-1.7%) |
| Nov 2015 | - | -20.39%(+468.0%) |
| Aug 2015 | - | -3.59%(-69.8%) |
| May 2015 | - | -11.87%(+148.3%) |
| Feb 2015 | -4.69%(-91.1%) | -4.78%(-5.3%) |
| Nov 2014 | - | -5.05%(-82.7%) |
| Aug 2014 | - | -29.11%(-12.3%) |
| May 2014 | - | -33.20%(-44.6%) |
| Feb 2014 | -52.96%(-5.4%) | -59.96%(-20.4%) |
| Nov 2013 | - | -75.28%(+11.4%) |
| Aug 2013 | - | -67.58%(+3.6%) |
| May 2013 | - | -65.26%(+18.3%) |
| Feb 2013 | -55.98%(-12.7%) | -55.15%(+6.2%) |
| Nov 2012 | - | -51.92%(-12.2%) |
| Aug 2012 | - | -59.12%(-5.3%) |
| May 2012 | - | -62.41%(-6.2%) |
| Feb 2012 | -64.15%(+2.7%) | -66.57%(-25.2%) |
| Nov 2011 | - | -89.02%(+3.6%) |
| Aug 2011 | - | -85.94%(-41.8%) |
| May 2011 | - | -147.75%(-141.5%) |
| Feb 2011 | -62.45%(+66.4%) | 356.13%(+112.6%) |
| Nov 2010 | - | 167.52%(+63.2%) |
| Aug 2010 | - | 102.64%(-35.4%) |
| May 2010 | - | 158.83%(-138.1%) |
| Feb 2010 | -37.54% | -417.17%(-1371.5%) |
| Nov 2009 | - | 32.81% |
FAQ
- What is Grace Therapeutics annual return on equity?
- What is the all time high annual ROE for Grace Therapeutics?
- What is Grace Therapeutics annual ROE year-on-year change?
- What is Grace Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Grace Therapeutics?
- What is Grace Therapeutics quarterly ROE year-on-year change?
What is Grace Therapeutics annual return on equity?
The current annual ROE of GRCE is -20.82%
What is the all time high annual ROE for Grace Therapeutics?
Grace Therapeutics all-time high annual return on equity is -4.69%
What is Grace Therapeutics annual ROE year-on-year change?
Over the past year, GRCE annual return on equity has changed by +41.62% (+66.66%)
What is Grace Therapeutics quarterly return on equity?
The current quarterly ROE of GRCE is -19.19%
What is the all time high quarterly ROE for Grace Therapeutics?
Grace Therapeutics all-time high quarterly return on equity is 356.13%
What is Grace Therapeutics quarterly ROE year-on-year change?
Over the past year, GRCE quarterly return on equity has changed by +39.69% (+67.41%)